期刊
TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY
卷 12, 期 4, 页码 215-219出版社
GALENOS YAYINCILIK
DOI: 10.4274/tjod.10576
关键词
Ectopic pregnancy; methotrexate; beta-hCG
Objective: Detection of factors that affect the success of single-dose methotrexate treatment in ectopic pregnancy. Materials and Methods: We investigated 99 patients who had been treated with single-dose methotrexate for ectopic pregnancy in our clinic between January 2009 and June 2014. Demographic, clinical, and laboratory results of possible factors that affect treatment success were retrospectively analyzed. Successfully and unsuccessfully treated patients were compared based on their pre-treatment results. Results: The success rate of single-dose methotrexate treatment was found to be 70.7%. No significant difference was found between succesfully and unsuccessfully treated patients before treatment in terms of factors such as gestational weeks, mass size, presence of yolk sac, and presence of free fluid (p=0.224, p=0.201, p=0.200, p=0.200). Serum beta-hCG values in patients whose treatment was unsuccessful was found to be higher compared with the successfully treated group (mean beta-hCG value of unsuccessful group: 4412 +/- 3501 mIU/mL; mean beta-hCG value of successful group: 1079 +/- 942 mIU/mL; p<0.001). Conclusion: Single-dose methotrexate treatment is an effective and reliable method in the treatment of ectopic pregnancy. Elevation of serum beta-hCG value stands as the main prognostic factor that affects the success of single-dose methotrexate treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据